Eli Lilly

Aktienkurs
1,058.56
Täglich Wechseln
49.04 4.86%
Monatlich
-0.39%
Jährlich
20.10%
Q1 Prognose
978.22




Ebitda Veränderung Datum
AbbVie USD 3.52B 828M 2025-09
Abbott USD 3.09B 44M 2025-09
ALKERMES USD 121.55M 4.99M 2025-09
Amgen USD 5.14B 775M 2025-12
AstraZeneca USD 5.23B 272M 2025-09
Baxter International USD 426M 36M 2025-09
Biogen USD 573.2M 253.7M 2025-12
Bristol-Myers Squibb USD 4.24B 967M 2025-09
Coherus Biosciences USD -44.34M 9.82M 2025-03
Drreddys Laboratories INR 21.59B 1.49B 2025-12
Eli Lilly USD 7.88B 378.1M 2025-09
Gilead Sciences USD 4.03B 628M 2025-09
GlaxoSmithKline GBP 3.36B 179M 2025-09
Glaxosmithkline GBP 4.75B 1.52B 2025-09
J&J USD 9.52B 389M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merck USD 8.39B 1.97B 2025-09
Neurocrine Biosciences USD 218.4M 28.3M 2025-12
Novartis USD 5.88B 290M 2025-09
Novartis USD 5.84B 235M 2025-09
Novo Nordisk DKK 37.3B 5.86B 2025-12
Perrigo USD 258.8M 37.3M 2025-09
Pfizer USD 6.08B 351M 2025-09
Phibro Animal Health USD 30.48M 1.1M 2024-09
Prestige Brands USD 90.82M 3.99M 2025-12
Regeneron Pharmaceuticals USD 1.92B 261.9M 2025-09
Roche Holding CHF 12.68B 2.36B 2024-06
Sanofi EUR 4.84B 2.95B 2025-09
Sanofi EUR 5.66B 3.77B 2025-09
United Therapeutics USD 436.8M 34.2M 2025-06
Zoetis USD 1.04B 87M 2025-09


Eli Lilly - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.